-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
CDH Fund
- Investments: 366
- Funds: 107
- Beijing
-
Grid/power transmission
Established in 2002, CDH Investments is one of the leading alternative investment fund managers focused on China today with over 1,726 yuan of assets under management, as of Sep, 2021. From its roots in private equity, CDH has expanded to become a diversified alternative asset management platform covering: Private Equity, Venture and Growth Capital, Securities Investment, Real Assets, Mezzanine Investment, and CDH Private Wealth Management. CDH Investments has successively invested in more than 300 enterprises in the fields of greater consumer products, medical and health care, enterprise services and hard technology innovation, of which 90 have been listed at home and abroad, and cultivated a number of industry leading brands.
-
CAS Investment
- Investments: 152
- Funds: 15
- Beijing
-
Grid/power transmission
CAS Investment Management Co., Ltd. (abbreviated as CASI)' s controlling shareholder is Chinese Academy of Sciences Holdings Co., Ltd. and has State-owned Assets Supervision and Administration Commission of the State Council and an employee-owned company as shareholders. Its predecessor is the Chinese National Economic Council-CAS Scientific and Technological Promotion & Economic Development Foundation. In 1993, it set up China Scientific and Technological Promotion Investment Company in line with Chinese policies governing foundations. In 2006, it was restructured into a limited liability company and changed to its present name. The key industries invested by CASI include instrumentation and high-end equipment manufacturing, information technology, pharmaceutical chemical industry and new materials, modern service industry, etc., and the company have successively supported more than 300 industrialization projects of scientific and technological achievements. CASI is committed to becoming a leading private equity fund manager in China.
-
Haier Capital
- Investments: 139
- Funds: 19
- Shanghai
-
Grid/power transmission
Haier Capital, founded in 2010, is the investment platform of Haier Financial Holding. Our business mainly involve venture capital, private equity investment, industrial mergers and acquisitions, and government guidance funds. Haier Capital focuses on the medical health field, including medical technology, medical services, medical equipments, and biomedicine. So far, we have managed more than 20 billion investment assets. We invest in smart technology, innovative consumption, andmedical health. The investment enterprises include Ijiami, Ubox, Dayun Motor, Dekun, Huatu Education, and Create LED.
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Grid/power transmission
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
-
SHENGZHEN Capital
- Investments: 1524
- Funds: 161
- Shenzhen, Guangdong Province
-
Grid/power transmission
Shenzhen Capital Group Co., Ltd. was established in 1999 with the investment of Shenzhen Municipal Government and social capitals. The company is committed to being the explorer and cultivator of innovation value, and has developed into a comprehensive investment group with venture capital as its core. With a registered capital of 10 billion yuan and a total scale of about 419.4 billion yuan under management, Shenzhen Capital Group now manages 172 private equity funds, 13 equity investment parent funds and 12 real estate funds. At the same time, the Group has the first public fund management company of venture capital in China-Hotland Innovation Asset Management. Shenzhen Capital Group mainly invests in small and medium-sized enterprises, independent innovation high-tech enterprises and emerging industrial enterprises, covering information technology, intelligent manufacturing, internet, consumer goods/modern services, biotechnology/health, new materials, new energy/energy conservation and environmental protection, and the whole life cycle of enterprises.